THE EFFECT OF TRYPANOSOMOSIS ON PLASMA PROTEIN LEVELS IN INDIGENOUS CATTLE

2021 ◽  
Vol 26 ◽  
pp. 125-128
Author(s):  
A. A. Adedapo ◽  
A. B. Saba ◽  
O. A. Dina ◽  
R. O. Arowolo
Keyword(s):  
Plasma Protein ◽  
Mixed Infection ◽  
Total Protein ◽  
Protein Level ◽  
Field Survey ◽  
Albumin Level ◽  
Indigenous Cattle ◽  
Protein Levels ◽  
Total Protein Level ◽  
Diagnostic Indices

A field survey involving 180 adult white Fulani cattle was carried out in the Guinea Savannah and Derived Savannah vegetational zones of South Western Nigeria to determine the effect of natural trypanosomal infection on plasma protein levels. Enzyme-linked immunosorbent examination were used as diagnostic indices. The results showed a prevalence of 36.7% mixed infection in the animals sampled. It was also observed that the albumin level was lowered, globulin level increased and the total protein level was slightly on the increase. Trypanosomal infection in this study therefore affects the concentration of total and differential plasma protein levels in indigenous cattle.  

Age-related changes in renal and hepatic cellular mechanisms associated with variations in rat serum thyroid hormone levels

2008 ◽  
Vol 294 (6) ◽  
pp. E1160-E1168 ◽  
Author(s):  
Elena Silvestri ◽  
Assunta Lombardi ◽  
Pieter de Lange ◽  
Luigi Schiavo ◽  
Antonia Lanni ◽  
...  
Keyword(s):  
Thyroid Hormone ◽  
Total Protein ◽  
Protein Level ◽  
Monocarboxylate Transporter ◽  
Type I ◽  
Peripheral Tissues ◽  
Protein Levels ◽  
Age Related ◽  
Liver And Kidney ◽  
Age Related Changes

Aging is associated with changes in thyroid gland physiology. Age-related changes in the contribution of peripheral tissues to thyroid hormone serum levels have yet to be systematically assessed. Here, we investigated age-related alterations in the contributions of the liver and kidney to thyroid hormone homeostasis using 6-, 12-, and 24-mo-old male Wistar rats. A significant and progressive decline in plasma thyroxine occurred with age, but triiodothyronine (T3) was decreased only at 24 mo. This was associated with an unchanged protein level of the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) in the kidney and with a decreased MCT8 level in the liver at 24 mo. Hepatic type I deiodinase (D1) protein level and activity declined progressively with age. Renal D1 levels were decreased at both 12 and 24 mo but D1 activity was decreased only at 24 mo. In the liver, no changes occurred in thyroid hormone receptor (TR) TRα1, whereas a progressive increase in TRβ1 occurred at both mRNA and total protein levels. In the kidney, both TRα1 and TRβ1 mRNA and total protein levels were unchanged between 6 and 12 mo but increased at 24 mo. Interestingly, nuclear TRβ1 levels were decreased in both liver and kidney at 12 and 24 mo, whereas nuclear TRα1 levels were unchanged. Collectively, our data show differential age-related changes among hepatic and renal MCT8 and D1 and TR expressions, and they suggest that renal D1 activity is maintained with age to compensate for the decrease in hepatic T3 production.

scholarly journals An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells

Blood ◽  
1992 ◽  
Vol 79 (11) ◽  
pp. 2930-2936 ◽  
Author(s):  
T Hayashi ◽  
G Honda ◽  
K Suzuki
Keyword(s):  
Endothelial Cells ◽  
Total Protein ◽  
Protein Level ◽  
Umbilical Vein ◽  
Mrna Level ◽  
Fold Increase ◽  
Immunoblot Analysis ◽  
Whole Cells ◽  
Total Protein Level ◽  
Cofactor Activity

Abstract Thrombomodulin plays a role as a cofactor for thrombin-catalyzed activation of protein C on endothelial cells. We examined the effect of homocysteine, a stimulant of atherosclerosis and thrombotic disease, on the cofactor activity and protein level of thrombomodulin and also on the expression of thrombomodulin in endothelial cells. Homocysteine inhibited the cofactor activity of thrombomodulin both on the surface of endothelial cells and in the whole cells dose- and time-dependently, and maximal inhibition of the cofactor activity occurred after a 3- to 6-hour incubation with 10 mmol/L homocysteine (10% of initial activity). Homocysteine also decreased the amount of intact (unreduced) thrombomodulin in endothelial cells. However, at the same condition the total protein level (reduced and unreduced form) of thrombomodulin, determined by dot immunoblot analysis using the monoclonal antibody that recognized both reduced and unreduced thrombomodulin, decreased slightly, and the mRNA level of thrombomodulin showed a twofold to three-fold increase. After 24 hours of incubation, the cofactor activity and total protein level of thrombomodulin were 60% and 165% of the initial values, respectively. When purified thrombomodulin fixed to a microwell plate was treated with homocysteine, both cofactor activity and thrombin-binding ability to the thrombomodulin were decreased in proportion to the concentration of homocysteine. These findings suggest that homocysteine directly inhibited the cofactor activity of thrombomodulin on endothelial cells by reducing the disulfide-bond rich epidermal growth factor-like structures of thrombomodulin. This would a result in the decrease of the antithrombotic property of endothelium and may also trigger off the synthesis of mRNA and protein of thrombomodulin to maintain the antithrombotic properties of the cells.

scholarly journals An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells

Blood ◽  
1992 ◽  
Vol 79 (11) ◽  
pp. 2930-2936 ◽  
Author(s):  
T Hayashi ◽  
G Honda ◽  
K Suzuki
Keyword(s):  
Endothelial Cells ◽  
Total Protein ◽  
Protein Level ◽  
Umbilical Vein ◽  
Mrna Level ◽  
Fold Increase ◽  
Immunoblot Analysis ◽  
Whole Cells ◽  
Total Protein Level ◽  
Cofactor Activity

Thrombomodulin plays a role as a cofactor for thrombin-catalyzed activation of protein C on endothelial cells. We examined the effect of homocysteine, a stimulant of atherosclerosis and thrombotic disease, on the cofactor activity and protein level of thrombomodulin and also on the expression of thrombomodulin in endothelial cells. Homocysteine inhibited the cofactor activity of thrombomodulin both on the surface of endothelial cells and in the whole cells dose- and time-dependently, and maximal inhibition of the cofactor activity occurred after a 3- to 6-hour incubation with 10 mmol/L homocysteine (10% of initial activity). Homocysteine also decreased the amount of intact (unreduced) thrombomodulin in endothelial cells. However, at the same condition the total protein level (reduced and unreduced form) of thrombomodulin, determined by dot immunoblot analysis using the monoclonal antibody that recognized both reduced and unreduced thrombomodulin, decreased slightly, and the mRNA level of thrombomodulin showed a twofold to three-fold increase. After 24 hours of incubation, the cofactor activity and total protein level of thrombomodulin were 60% and 165% of the initial values, respectively. When purified thrombomodulin fixed to a microwell plate was treated with homocysteine, both cofactor activity and thrombin-binding ability to the thrombomodulin were decreased in proportion to the concentration of homocysteine. These findings suggest that homocysteine directly inhibited the cofactor activity of thrombomodulin on endothelial cells by reducing the disulfide-bond rich epidermal growth factor-like structures of thrombomodulin. This would a result in the decrease of the antithrombotic property of endothelium and may also trigger off the synthesis of mRNA and protein of thrombomodulin to maintain the antithrombotic properties of the cells.

scholarly journals ELEKTROFORESIS PROTEIN SERUM PASIEN DENGAN KADAR PROTEIN NORMAL

2018 ◽  
Vol 15 (3) ◽  
pp. 87
Author(s):  
Tiene Rostini ◽  
Coriejati Rita
Keyword(s):  
Serum Protein ◽  
Total Protein ◽  
Protein Level ◽  
Protein Electrophoresis ◽  
Serum Protein Electrophoresis ◽  
Total Protein Level ◽  
Normal Limits ◽  
Nephritic Syndrome ◽  
Serum Protein Level ◽  
Electrophoresis Pattern

Serum protein electrophoresis pattern can assist in diagnosis of liver disease, hematological disorders, renal disorders andgastrointestinal disease. Measurement of total protein level in the serum cannot detect any disorders in patient with normal limit ofserum total protein level. The aim of this study; was to evaluate the serum protein electrophoresis pattern in patient with normal limitsof serum protein level. This research was carried out by descriptive retrospective study using the electrophoresis data from patients’medical record at the Clinical Pathology Department, Dr. Hasan Sadikin General Hospital Bandung. The data of serum electrophoresis (bySebia gel electrophoresis) were grouped based on disease or disorders, and confirmed with the diagnosis derived from patient’s medicalrecord. Inclusion criteria of samples if ; the electrophoresis data were available, serum total protein level within normal limits (6.4–8.3mg/dL), and the data of electrophoresis taken from medical record were taken from August 2006 until August 2008. The result foundso far was, there were 240 data of electrophoresis from patients with serum protein level within normal limits (6.4–8.3 mg/dL). theinterpretation of electrophoresis consist of: 1) inflammation (149 patients; 62.2% ; sensitivity 83.7%, specificity 86,5%) 2) Cirrhosis(46 patients ; 19.2% ; sensitivity 87.5% ; specificity 88.4%) 3) Nephritic syndrome (15 patients ; 6.2%; sensitivity 53%; specificity96.9% 4) Monoclonal gammophaty (15 patients(6.2% ; sensitivity 80% ; specificity 98.7%) 5) Normal pattern in 15 patient (6.2%).This study found abnormal serum protein electrophoresis pattern in the condition of inflammation, Cirrhosis, Nephritic Syndrome, andMonoclonal gammophaty. It can be concluded that many disorders could be detected in patient with serum protein level within normallimits such as: inflammation, cirrhosis, nephritis syndrome and monoclonal gammophaty by abnormal electrophoresis pattern

scholarly journals Protective Effect of Terminalia Chebula Extract on Serum Total Protein against

2017 ◽  
Vol 46 (1) ◽  
pp. 11-14
Author(s):  
Tania Yeasmin ◽  
Kazi Shamima Akhter ◽  
Masud Imtiaz
Keyword(s):  
Protective Effect ◽  
Total Protein ◽  
Protein Level ◽  
Control Group ◽  
Albino Rats ◽  
Terminalia Chebula ◽  
Serum Total Protein ◽  
Medical College ◽  
Total Protein Level ◽  
Serum Total Protein Level

Terminalia Chebula extract is used for regeneration of hepatic cells and protection of liver against damage due to its active component. This study aims to observe the protective effect of Terminalia Chebula against Paracetamol induced change of serum total protein level in Wister Albino rats. The study was carried out in the Department of Physiology, Dhaka Medical College (DMC) during January 2013 to December 2013. A total number of 44 rats, age ranging from 90 to 120 days, weight between 150 to 200 gm (initial body weight) were selected for the study. After acclimatization for 14 days, they were divided into control groups and experimental groups. Before sacrifice, final body weights of all the rats were measured. then all the rats were sacrificed on 22nd day and then blood samples were collected. For assessment of liver function, serum total protein level was done by using standard laboratory kits. The mean serum total protein level was significantly (p<0.001) lower in paracetamol treated control group in comparison to those of baseline control group. Serum total protein level of all experimental groups were significantly (P<0.001) higher than Paracetamol treated control group. From the results of this study, it may be concluded that Terminalia Chebula may have some protective effect against Paracetamol induced liver damage in rats.Bangladesh Med J. 2017 Jan; 46 (1): 11-14

Total Protein Level in Cerebrospinal Fluid is Stable in Elderly Adults

2013 ◽  
Vol 61 (10) ◽  
pp. 1819-1821 ◽  
Author(s):  
Diane Dufour-Rainfray ◽  
Emilie Beaufils ◽  
Patrick Vourc'h ◽  
Emilie Vierron ◽  
Laurent Mereghetti ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Total Protein ◽  
Protein Level ◽  
Elderly Adults ◽  
Total Protein Level

Total plasma protein level as an indicator of condition in wild American kestrels (Falco sparverius)

1997 ◽  
Vol 75 (5) ◽  
pp. 680-686 ◽  
Author(s):  
Russell D. Dawson ◽  
Gary R. Bortolotti
Keyword(s):  
Plasma Protein ◽  
Protein Level ◽  
Egg Laying ◽  
Falco Sparverius ◽  
Total Plasma ◽  
Protein Levels ◽  
American Kestrels ◽  
Total Plasma Protein ◽  
In The Wild ◽  
Plasma Protein Level

Total plasma protein levels were determined for 292 female and 228 male American kestrels (Falco sparverius) in the wild. Plasma protein levels were significantly higher in females than in males, and higher during prelaying than during incubation. For both sexes, plasma protein levels did not vary significantly with the number of days before or after egg laying on which the sample was taken, time of sampling, prey abundance, age, molt, or infection by the blood parasite Haemoproteus sp. Protein levels in females increased with date of sampling and body condition during prelaying, while the same pattern was seen in males during incubation. With the exception of those of prelaying females, plasma protein levels increased with ambient temperature. The results of this study suggest that at least some of the variation observed in total protein levels is attributable to physical condition. However, further investigation is required before the reliability of using total plasma protein level as a tool to assess the health and condition of kestrels is known.

scholarly journals EFFECTS OF A TYPICAL ANTIPSYCHOTIC AND THROMBOXANE A2 SYNTHASE INHIBITOR DRUG COMBINATION ON ALBUMIN AND TOTAL PROTEIN LEVEL WITH DIFFERENT DOSES IN RATS

2019 ◽  
pp. 316-319
Author(s):  
MUHAMMAD IRFAN BASHIR
Keyword(s):  
Total Protein ◽  
Protein Level ◽  
Maximum Dose ◽  
Thromboxane A2 ◽  
Treated Group ◽  
Albino Rats ◽  
Typical Antipsychotic ◽  
Blood Samples ◽  
Total Protein Level ◽  
Synthase Inhibitor

Objective: The objective of this study was to investigate the combined as well as individual effects of a typical antipsychotic and thromboxane A2 synthase inhibitor on albumin and total protein level with minimum and maximum dose comparison in rats. Methods: This study consisted of 100 albino rats of 300 to 340 g from both gender, there were 10 groups, each contained 10 rats (n=10). Rats were treated with defined dose of zuclopenthixol (Zuclo) and ozagrel (Ozg) for 21 days (3 weeks). Blood samples were collected at 0, 7th, 14th, and 21st days of study. Albumin and total protein level were examined from blood samples using standard laboratory procedure. Results are extracted by applying statistical analysis on data and comparing percentage variation from 0-day value. Results: A typical antipsychotic-treated group showed gradually significant increase in albumin and total protein level, TXA2 synthase inhibitor-treated group also showed significant gradually increase in albumin and total protein level in combination groups, they showed highly significant increase p<0.001 in both parameter with maximum dose. Conclusion: Combination treatment with zuclopenthixol (Zuclo) and ozagrel (Ozg) can cause large increase on albumin and total protein level with maximum dose as compare to individual drug treatment.

Sign in / Sign up

Export Citation Format

Share Document